These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 22790074)

  • 1. Prevention of cardiovascular disease after renal transplantation.
    Svensson M; Jardine A; Fellström B; Holdaas H
    Curr Opin Organ Transplant; 2012 Aug; 17(4):393-400. PubMed ID: 22790074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors for and management of post-transplantation cardiovascular disease.
    Fellström B
    BioDrugs; 2001; 15(4):261-78. PubMed ID: 11437691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cardiovascular disease after renal transplantation].
    Montanaro D; Gropuzzo M; Tulissi P; Boscutti G; Risaliti A; Baccarani U; Adani GL; Sainz M; Bresadola F; Mioni G
    G Ital Nefrol; 2004; 21 Suppl 26():S53-66. PubMed ID: 15732047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Metabolic disorders in renal transplant recipients].
    Mikolasević I; Jelić I; Sladoje-Martinović B; Orlić L; Zivcić-Cosić S; Vuksanović-Mikulicić S; Mijić M; Racki S
    Acta Med Croatica; 2012 Jul; 66(3):235-41. PubMed ID: 23441539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors for cardiovascular disease in renal transplant recipients and strategies to minimize risk.
    Liefeldt L; Budde K
    Transpl Int; 2010 Dec; 23(12):1191-204. PubMed ID: 21059108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hypertension after kidney transplantation].
    Racki S
    Lijec Vjesn; 2006; 128(11-12):373-8. PubMed ID: 17212200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular complications of immunosuppressive agents in renal transplant recipients.
    Olyaei AJ; Demattos AM; Bennett WM
    Expert Opin Drug Saf; 2005 Jan; 4(1):29-44. PubMed ID: 15709896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors of long-term graft loss in renal transplant recipients with chronic allograft dysfunction.
    Khalkhali HR; Ghafari A; Hajizadeh E; Kazemnejad A
    Exp Clin Transplant; 2010 Dec; 8(4):277-82. PubMed ID: 21143092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pretransplant cardiovascular evaluation and posttransplant cardiovascular risk.
    Young JB; Neumayer HH; Gordon RD
    Kidney Int Suppl; 2010 Sep; (118):S1-7. PubMed ID: 20706223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of cardiovascular disease and risk factor treatment on ethnic disparities in kidney transplant.
    Taber DJ; Pilch NA; Meadows HB; McGillicuddy JW; Bratton CF; Chavin KD; Baliga PK; Egede LE
    J Cardiovasc Pharmacol Ther; 2013 May; 18(3):243-50. PubMed ID: 23258931
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The influence of pre-operative electrocardiographic abnormalities and cardiovascular risk factors on patient and graft survival following renal transplantation.
    Woo YM; McLean D; Kavanagh D; Ward L; Aitken S; Miller GJ; Egan P; Hughes K; Clark L; Carswell K; Morris ST; Northridge DB; Rodger RS; Jardine AG
    J Nephrol; 2002; 15(4):380-6. PubMed ID: 12243367
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiovascular disease after renal transplantation.
    Kasiske BL
    Semin Nephrol; 2000 Mar; 20(2):176-87. PubMed ID: 10746859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Factors determining cardiovascular disease progression after kidney transplant].
    Scolari MP; La Manna G; Cianciolo G; Cappuccilli ML; Lanci N; Donati G; Persici E; Cuna V; Feliciangeli G; Liviano D'Arcangelo G; Mosconi G; Stefoni S
    G Ital Nefrol; 2009; 26 Suppl 46():30-43. PubMed ID: 19644816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiovascular disease in renal transplant recipients.
    McQuarrie EP; Fellström BC; Holdaas H; Jardine AG
    J Ren Care; 2010 May; 36 Suppl 1():136-45. PubMed ID: 20586909
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiovascular disease in live related renal transplantation.
    Kaul A; Sharm RK; Gupta A; Sinha N; Singh U
    J Assoc Physicians India; 2011 Nov; 59():715-8. PubMed ID: 22616338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence evolution and impact of cardiovascular risk factors on allograft and renal transplant patient survival.
    Díaz JM; Gich I; Bonfill X; Solà R; Guirado L; Facundo C; Sainz Z; Puig T; Silva I; Ballarín J
    Transplant Proc; 2009; 41(6):2151-5. PubMed ID: 19715859
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunosuppressive agents and metabolic factors of cardiovascular risk in renal transplant recipients.
    Sessa A; Esposito A; Giliberti A; Iavicoli G; Costa C; Bergallo M; Lettieri E; Rossano R; Capuano M
    Transplant Proc; 2009 May; 41(4):1178-82. PubMed ID: 19460510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiovascular risk in kidney transplant recipients receiving mammalian target of rapamycin inhibitors.
    Watorek E; Szymczak M; Boratynska M; Patrzalek D; Klinger M
    Transplant Proc; 2011 Oct; 43(8):2967-9. PubMed ID: 21996202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiovascular Disease After Kidney Transplant.
    Rao NN; Coates PT
    Semin Nephrol; 2018 May; 38(3):291-297. PubMed ID: 29753404
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lower homocysteine levels in renal transplant recipients treated with everolimus: a possible link with a decreased cardiovascular risk?
    Farsetti S; Zanazzi M; Caroti L; Rosso G; Larti A; Marcucci R; Fedi S; Rogolino A; Cellai AP; Abbate R; Bertoni E; Salvadori M
    Transplant Proc; 2010 May; 42(4):1381-2. PubMed ID: 20534308
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.